Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the use of a low dose sugammadex and neostigmine combined
to glycopyrrolate to reverse a rocuronium induced moderate neuromuscular blockade.